No Surprise: DSCSA Verification Delay
FDA delays one wholesaler requirement, plus, Ilisa Bernstein leaves FDA
FDA delays one wholesaler requirement, plus, Ilisa Bernstein leaves FDA
Could the FDA delay enforcement of the wholesaler’s 2019 DSCSA requirements?
Here are some resources for meeting wholesaler requests for their DSCSA obligations.
HDA responds to FDA’s draft guidance on Verification Systems. A must-read.
Most companies will do verification wrong, because they haven’t read the DSCSA or FDA draft guidance…or RxTrace.
GS1’s new standard for verification messaging. Does it apply to you? Probably.
Verification Systems under the DSCSA are the things that FDA (and probably state) inspectors are going to look for whenever they visit your facilities from now on. Are you ready? This new draft guidance will help you.
Verification is arguably the most important concept in drug serialization and tracing regulations. What makes it so hard to get right?
DISCLAIMER: RxTrace contains some of the personal thoughts, ideas and opinions of RxTrace. The material contained in RxTrace is not legal advice. The writers of RxTrace are not lawyers.
The reader must make their own decisions about the accuracy of the opinions expressed in RxTrace. Readers are encouraged to consult their own legal counsel
and trading partners before taking any actions based on information found in RxTrace. RxTrace is not a vehicle for communicating
the positions of any company, organization or individual other than RxTrace.
RxTrace, a comprehensive exploration of the intersection between healthcare supply chains, track and trace technology, standards and global regulatory compliance.
Contact Us | Privacy Statement
Copyright © 2009-2021 TrackTraceRx, Inc. All Rights Reserved.
RxTrace is a registered trademark of TrackTraceRx, Inc